Advertisement

Topics

NeuralStem Company Profile

13:34 EDT 18th June 2018 | BioPortfolio

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and Merrill Solomon. The Company was founded in 1996.

Location

9700 Great Seneca Highway
Rockville
MD
20850
United States of America

Contact

Phone: 301.366.4960
Fax: 301-330-1055
Email: neuralsteminfo@neuralstem.com


News Articles [19 Associated News Articles listed on BioPortfolio]

Neuralstem - Burning Cash, Looking For Answers

New Member appointed to the Board of Directors of Neuralstem

GERMANTOWN, Md., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Xi Chen...

Neuralstem to Participate at the BIO 2018 International Convention

GERMANTOWN, Md., May 29, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Karl Johe,...

Neuralstem to Participate at Upcoming Investor Conferences

GERMANTOWN, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that member...

Neuralstem to Participate at Cell and Gene Therapy World

GERMANTOWN, Md., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl J...

Neuralstem (CUR) Presents At ARM's 6th Cell & Gene Therapy Investor Day - Slideshow

Neuralstem to Participate at The Young Jewish Professionals CEO Healthcare Symposium

GERMANTOWN, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that R...

Neuralstem Provides Business Update and Reports First Quarter 2018 Fiscal Results

GERMANTOWN, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell tec...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NeuralStem

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and...

Neuralstem Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the d...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability...

More Information about "NeuralStem" on BioPortfolio

We have published hundreds of NeuralStem news stories on BioPortfolio along with dozens of NeuralStem Clinical Trials and PubMed Articles about NeuralStem for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuralStem Companies in our database. You can also find out about relevant NeuralStem Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record